Reinfusion of autologous peripheral blood stem cells after high-dose chemotherapy via a Port-a-cath is a safe and feasible procedure and does not compromise successful engraftment

被引：0
|
作者：
Alietti, A. [1 ]
Andreola, G. [1 ]
Orlando, L. [1 ]
Negri, M. [1 ]
Rabascio, C. [1 ]
Vanazzi, A. [1 ]
Babic, A. [1 ]
Roveda, L. [1 ]
Lucchetti, B. [1 ]
Sammassimo, S. [1 ]
Nassi, L. [1 ]
Clerici, M. [1 ]
Magri, R. [1 ]
Laszlo, D. [1 ]
Martinelli, G. [1 ]
机构：
[1] European Inst Oncol, Milan, Italy
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S113 / S114
页数：2
相关论文
共 50 条
  • [41] Efficiency of high-dose FEC chemotherapy for mobilizing hematopoietic stem cells into peripheral blood
    DHondt, L
    Andre, M
    Canon, JL
    Guillaume, T
    Doyen, C
    Feyens, AM
    Chatelain, B
    Dromelet, A
    Humblet, Y
    Longueville, J
    Symann, M
    [J]. BULLETIN DU CANCER, 1997, 84 (07) : 729 - 733
  • [42] Use of amifostine as a chemoprotectant during high-dose chemotherapy in autologous peripheral blood stem cell transplantation
    Cronin, S
    Uberti, JP
    Ayash, LJ
    Raith, C
    Ratanatharathorn, V
    [J]. BONE MARROW TRANSPLANTATION, 2000, 26 (11) : 1247 - 1249
  • [43] A CASE OF MEDULLOEPITHELIOMA TREATED BY HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION (PBSCT)
    Hayase, Tomomi
    Kawahara, Yuta
    Yagi, Masaki
    Minami, Takaomi
    Kanai, Nobuyuki
    Yamaguchi, Takehiko
    Gomi, Akira
    Morimoto, Akira
    [J]. NEURO-ONCOLOGY, 2014, 16 : 73 - 74
  • [44] Use of amifostine as a chemoprotectant during high-dose chemotherapy in autologous peripheral blood stem cell transplantation
    S Cronin
    JP Uberti
    LJ Ayash
    C Raith
    V Ratanatharathorn
    [J]. Bone Marrow Transplantation, 2000, 26 : 1247 - 1249
  • [45] Infectious complications after high-dose therapy with autologous peripheral blood stem cell transplantation
    Sezer, O
    Eucker, J
    Fuss, H
    Bauhuis, C
    Kobert, U
    Heinzel, W
    Späth-Schwalbe, E
    Arnold, R
    Possinger, K
    Schultze, W
    [J]. HIGH-DOSE THERAPY AND TRANSPLANTATION OF HAEMATOPOIETIC STEM CELLS, 2000, : 90 - 93
  • [46] Bone marrow but not peripheral blood stem cell transplantation performed 72 hrs after high-dose chemotherapy is associated with faster engraftment
    Hansz, J
    Kozlowska-Skrzypczak, M
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 : S73 - S73
  • [47] High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to neoadjuvant chemotherapy
    N T Ueno
    S Konoplev
    T A Buchholz
    T Smith
    G Rondón
    P Anderlini
    S A Giralt
    J L Gajewski
    M L Donato
    M Cristofanilli
    R E Champlin
    [J]. Bone Marrow Transplantation, 2006, 37 : 929 - 935
  • [48] High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to neoadjuvant chemotherapy
    Ueno, NT
    Konoplev, S
    Buchholz, T
    Smith, T
    Rondón, G
    Anderlini, P
    Giralt, S
    Gajewski, JL
    Donato, ML
    Cristofanilli, M
    Champlin, R
    [J]. BONE MARROW TRANSPLANTATION, 2006, 37 (10) : 929 - 935
  • [49] Lenograstim and filgrastim are equally effective for the hematopoeitic recovery after high-dose chemotherapy and autologous peripheral blood stem cell transplantation
    Teschendorf, C.
    Karaivanova, D.
    Koldehoff, M.
    Schmiegel, W.
    Graeven, U.
    [J]. ONKOLOGIE, 2010, 33 : 140 - 140
  • [50] Rituximab does not compromise the mobilization and engraftment of autologous peripheral blood stem cells in diffuse-large B-cell lymphoma
    K Kamezaki
    Y Kikushige
    A Numata
    T Miyamoto
    K Takase
    H Henzan
    K Aoki
    K Kato
    A Nonami
    T Kamimura
    F Arima
    K Takenaka
    N Harada
    T Fukuda
    S Hayashi
    Y Ohno
    T Eto
    M Harada
    K Nagafuji
    [J]. Bone Marrow Transplantation, 2007, 39 : 523 - 527
12345